SDHD Gene Paragangliomas Type 1 with or without Deafness Genetic Test
At DNA Labs UAE, we offer the SDHD Gene Paragangliomas Type 1 with or without Deafness Genetic Test. This test helps in detecting mutations or changes in the SDHD gene, which is associated with paragangliomas, rare tumors that develop in nerve tissue in areas like the head, neck, and abdomen. The SDHD gene is also linked to the development of deafness in some individuals with paragangliomas.
Test Components and Price
The SDHD Gene Paragangliomas Type 1 with or without Deafness Genetic Test costs 4400.0 AED. The test is performed using next-generation sequencing (NGS) technology.
Sample Condition and Report Delivery
The test requires a blood or extracted DNA sample. Alternatively, one drop of blood can be collected on an FTA card. The report is typically delivered within 3 to 4 weeks.
Test Type and Referring Doctor
The SDHD Gene Paragangliomas Type 1 with or without Deafness Genetic Test is a cancer genetic test. It is referred by oncologists.
Test Department
The test is conducted in our Genetics department.
Pre Test Information
Prior to the test, we recommend providing the clinical history of the patient who is undergoing the SDHD Gene Paragangliomas Type 1 with or without Deafness Genetic Test. Additionally, a genetic counseling session is conducted to create a pedigree chart of family members affected by SDHD Gene Paragangliomas Type 1 with or without Deafness NGS Genetic DNA Test gene SDHD.
Test Details
The SDHD Gene Paragangliomas Type 1 with or without Deafness Genetic Test utilizes next-generation sequencing (NGS) technology to analyze the DNA sequence of the SDHD gene. This helps in identifying any mutations or changes that may be present. The test is typically performed on a blood or saliva sample. The results aid in diagnosing individuals with paragangliomas and determining the risk of deafness associated with the SDHD gene mutation. This information is valuable in guiding medical management and treatment decisions for individuals and their families.
| Test Name | SDHD Gene Paragangliomas type 1 with or without deafness Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SDHD Gene Paragangliomas type 1, with or without deafness NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SDHD Gene Paragangliomas type 1, with or without deafness NGS Genetic DNA Test gene SDHD |
| Test Details | SDHD gene paragangliomas type 1, with or without deafness NGS genetic test is a type of genetic test that is used to detect mutations or changes in the SDHD gene. This gene is associated with paragangliomas, which are rare tumors that develop in the nerve tissue of certain areas of the body, such as the head, neck, and abdomen. The SDHD gene is also associated with the development of deafness in some individuals with paragangliomas. This genetic test uses next-generation sequencing (NGS) technology to analyze the DNA sequence of the SDHD gene and identify any mutations or changes that may be present. The test is typically performed on a blood or saliva sample, and the results can help diagnose individuals with paragangliomas and determine the risk of deafness associated with the SDHD gene mutation. This information can be useful for guiding medical management and treatment decisions for individuals and their families. |
